A medical device company developed a groundbreaking wearable device designed to provide real-time monitoring for chronic conditions. While the technology was innovative, the company struggled to communicate its value to both patients and healthcare professionals (HCPs).

A pharmaceutical company sought to improve adherence to a medication for chronic obstructive pulmonary disease (COPD). However, existing patient materials were overly technical and lacked emotional resonance. This disconnect made it difficult for patients to see the personal benefits of treatment, leading to poor adherence and engagement.